Skip to main content
. 2019 Jul 29;9:11004. doi: 10.1038/s41598-019-47369-0

Figure 2.

Figure 2

The NK-1R increases SCF production, but does not alter MC proliferation or apoptosis. (A) Stem cell factor levels for SHR, WKY, and SHR treated with the NK-1R antagonist L732138 (5 mg/kg/d). All values are mean ± SEM; n = 6–8; ***P < 0.001, ****P < 0.0001; (B) In situ hybridization identifying cells expressing SCF (antisense) in the left ventricle. Endothelial cells and cardiomyocytes labeled positive for stem cell factor (black arrows). Incubation with sense probes served as the negative control; (C) Flow cytometry analysis of BMMCs (FcεRI+ cells) indicating that 95% of BMMCs possess the NK-1R; (D) c-kit protein levels on BMMCs as determined by ELISA; (E) BMMC proliferation assay (n = 12); Quantification of cleaved caspase-3 (F) and apoptosis inducing factor (AIF) (G); Representative western blots for cleaved caspase-3 and AIF (H) from BMMCs treated with SP (n = 6). All values are mean ± SEM. Gel images in (D) are cropped from three separate blots. Images of full-length blots are included in Fig. S7.